![Karen Akinsanya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Akinsanya
Chief Tech/Sci/R&D Officer at
SCHRÖDINGER, INC.
Net worth: 97 063 $ as of 2026-07-30
Profile
Dr. Karen Akinsanya is an Independent Director at Nautilus Biotechnology, Inc., a Chief Strategy Officer & President-Partnerships at Schrödinger, Inc. and a President at Envision Science Group LLC.
She is on the Board of Directors at Nautilus Biotechnology, Inc. and The Rockefeller University.
Dr. Akinsanya was previously employed as an Associate Vice President by Merck & Co., Inc. She received her undergraduate degree from Queen Mary University of London and a doctorate degree from Imperial College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCHRODINGER, INC. 0.01% | 2026-03-31 | 6,411 ( 0.01% ) | 97 063 $ | 2026-07-30 |
| 2026-06-17 | 0 ( -.--% ) | - $ | 2026-07-30 |
Karen Akinsanya active positions
| Companies | Position | Start |
|---|---|---|
| SCHRÖDINGER, INC. | Chief Tech/Sci/R&D Officer | 2022-03-31 |
| NAUTILUS BIOTECHNOLOGY, INC. | Director/Board Member | 2022-03-29 |
Envision Science Group LLC | Founder | 2006-12-31 |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Former positions of Karen Akinsanya
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 2017-06-30 |
Training of Karen Akinsanya
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Queen Mary University of London
 Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nautilus Biotechnology, Inc.
 Nautilus Biotechnology, Inc. BiotechnologyHealth Technology Develops proteomics platform for analyzing and quantifying the human proteome | Health Technology |
Envision Science Group LLC |
- Stock Market
- Insiders
- Karen Akinsanya
